Vimarsana
Biggest News Aggregation in the World

Page 2 - Acetate Injection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acetate Injection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acetate Injection Today - Breaking & Trending Today

Medication Error Possible if Incompatible Autoinjector Used to Administer MS Drug - Vimarsana News

Medication Error Possible if Incompatible Autoinjector Used to Administer MS Drug

The FDA has issued a safety communication regarding cross-compatibility issues with autoinjector devices that are optional for use with glatiramer acetate injection.

Source: empr.com
Fertility Drugs Global Market Report 2022: Featuring Key - Vimarsana News

Fertility Drugs Global Market Report 2022: Featuring Key

Dublin, Aug. 05, 2022 (GLOBE NEWSWIRE) -- The "Fertility Drugs Global Market Report 2022, Gender, Route of Administration, Type Of Drug, Distribution...

Fertility Drugs Global Market to Reach $3.4 Billion by 2026 at a CAGR of 3.9% - Vimarsana News

Fertility Drugs Global Market to Reach $3.4 Billion by 2026 at a CAGR of 3.9%

/PRNewswire/ -- The "Fertility Drugs Global Market Report 2022, Gender, Route of Administration, Type Of Drug, Distribution Channel" report has been added to...

Aurobindo Pharma bags USFDA approval for Leuprolide Acetate Injection; stock slips ~1% - Vimarsana News

Aurobindo Pharma bags USFDA approval for Leuprolide Acetate Injection; stock slips ~1%

Leuprolide Acetate for injection is indicated for the treatment used to treat the symptoms associated with advanced prostate cancer by way of Palliative treatment of advanced prostatic cancer.

Eugia Pharma gets USFDA approval - Vimarsana News

Eugia Pharma gets USFDA approval

Uniindia: Hyderabad, June 7 (UNI) Aurobindo Pharma Ltd on Tuesday announced that its wholly owned subsidiary, Eugia Pharma Specialties Ltd, has received a final approval from the US Food and Drug Administration (USFDA) to manufacture and market Leuprolide Acetate Injection, 14 mg/2.8 mL MDV (Kit).